Mirtazapine EP Impurity E is a known related compound associated with the synthesis, degradation, or manufacturing process of Mirtazapine. It is commonly used as a reference standard for impurity profiling and analytical studies.

Mirtazapine EP Impurity E helps pharmaceutical companies identify, quantify, and monitor impurities, ensuring product quality and regulatory compliance.

Mirtazapine EP Impurity E can be analyzed using HPLC, UPLC, LC-MS, GC-MS (where applicable), and other advanced chromatographic and spectroscopic techniques.

Yes, Mirtazapine EP Impurity E is widely used as a reference standard for qualitative and quantitative analysis of impurities in pharmaceutical products.

It assists in establishing specificity, accuracy, precision, linearity, detection limits, and quantification limits during analytical method validation studies.

Mirtazapine EP Impurity E can be sourced from Chemicea, a trusted supplier of pharmaceutical impurities, reference standards, metabolites, and analytical research materials for the pharmaceutical industry.

Mirtazapine EP Impurity E may form during the synthesis, purification, storage, or degradation of the parent drug substance under specific process or environmental conditions.

Chemicea provides COA, H-NMR, MASS, HPLC, and TGA reports as standard with Mirtazapine EP Impurity E. Additional reports such as CNMR, IR, UV, DEPT, Water Content, and CHNS can be provided upon request, subject to availability.

The CAS number for Mirtazapine EP Impurity E is 191546-94-8.